Jasmohan Bajaj
@JasmohanBajaj
Liver specialist at Virginia Commonwealth University and Richmond VAMC . Interested in the brain liver gut axis. Co-EIC of Am J Gastro. Tweets are personal.
🙏 @AmJGastro for highlighting this! We need to do a better job advocating for our patients with #hepaticencephalopathy for transplant priority. @ISHENliver @AmCollegeGastro @VCU_Liver @AASLDtweets @ASTSChimera @EASLnews @APASLnews @ebtapper @RajivJalan1 @DebbieShawcros1
Enhancement of Cirrhosis Mortality Prediction by Including Hepatic Encephalopathy to MELD 3.0 in a National Veteran Cohort Silvey, et al. 📕 doi.org/10.14309/ajg.0… @nilangpatel @DrJackieOleary @JasmohanBajaj @MLongMD
Join us for the 2nd edition of AIG Liver Conclave on 26th and 27th September at Hyderabad . @MajaThiele @gvraoaig @ebtapper @JasmohanBajaj @ArunJSanyalVCU @ProfPaoloAngeli @ajay_duseja @DrMarkMuthiah @KailashKolhe @RoyAHep @drnipunverma @INASL_Liver @VCU_Liver #liverx
Join us at the AIG Liver Conclave 2025 on 26–27 September at HICC, Hyderabad, for power-packed lectures that tackle some of the most challenging fronts in liver medicine. A deep dive into MetALD (Metabolic Dysfunction–Associated Alcohol-Related Liver Disease), an emerging…
Thanks to @inside_PM for the opportunity for @jasmohanbajaj to talk about new paper, AI Foresees Death After Cirrhosis Hospitalization insideprecisionmedicine.com/topics/patient…
We are pleased to announce that registration for ISHEN2025 is now open! ishen.org/ishen-2025/reg… We are accepting late breaking abstracts ishen.org/ishen-2025/abs… NOTE: There is very limited space. Registration will be open until full capacity 👉 Register today!
Published on behalf of @CLEARED_liver @ILBS_India @VCU_Liver @VAResearch gastrojournal.org/article/S0016-… @nilangpatel @PaulMoayyedi
🤖🧠 An AI model accurately predicted inpatient death on day 1 of admission in patients with #cirrhosis. Developed by @JasmohanBajaj and colleagues @VCU, and published in @AGA_Gastro — it may help guide timely, individualized decisions. #LiverHealth bit.ly/3H3elu1
Vonoprazan High-dose Dual, Vonoprazan Triple and Rabeprazole Reverse Hybrid Therapies for First-line Treatment of H. pylori Infection: A Multicenter Randomized Trial Hsu, et al. 📕 doi.org/10.14309/ajg.0… @MLongMD @JasmohanBajaj
Check out practical advice 📝 on Monitoring Inflammatory Bowel Disease Activity: When, How, and Why In @AmCollegeGastro @AmJGastro with @JillGaidosMD ✅ for: 🚽🩸Clinical response and remission 🧪💩💉Biochemical 🧐🔎🔬Endoscopic 🩻 Radiographic pubmed.ncbi.nlm.nih.gov/40488637/
Definitions of #liver failure vary➡️tower of Babel in #ACLF Enter @CLEARED_liver with 🌎 input (>120 sites) @AGA_CGH 🔑 liver failure=bili >7.5, INR>1.5 & grade2 #HE ➡️ death 🔑 validated in @MayoClinicGIHep pubmed.ncbi.nlm.nih.gov/40618943/ Informed pubmed.ncbi.nlm.nih.gov/40499736/ @AGA_Gastro
Fruits, Vegetables, Legumes and Potatoes and Risk of Crohn’s Disease and Ulcerative Colitis Meyer, et al. 📕 doi.org/10.14309/ajg.0… @ChristinaDahm @AuneDagfinn @UMCU_Intl @tammy_tong @MLongMD @JasmohanBajaj
Birth Outcomes in Women Who Have Taken Vedolizumab in Pregnancy: Results from the Vedolizumab Pregnancy Exposure Registry Chambers, et al. 📕 doi.org/10.14309/ajg.0… @MLongMD @JasmohanBajaj
Cardiovascular Risk Assessment Tools are Insufficient for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Barritt, et al. 📕 doi.org/10.14309/ajg.0… @sidbarritt4 @ebtapper @DrLoomba @ArunJSanyalVCU @TargetRWE @MLongMD @JasmohanBajaj
The Magnetic Flexible Endoscope: Phase 1 First-in-Human Clinical Trial Obstein, et al. 📕 doi.org/10.14309/ajg.0… @KeithObstein @PietroValda @MLongMD @JasmohanBajaj
🆕 ACG 2025 IBD Preventive Care 🦠 Vaccines ▪️PCV 20/21 for all adults ▪️Zoster ≥19 if suppressed ▪️Flu q1y (high dose ≥65) ▪️HBV if non-immune ▪️RSV ≥60 if risk factors 🧬 Cancer ▪️Cervical: if immunotherapy ▪️Skin: q1y, esp if on thiopurines/JAKs 🔗bit.ly/acg-ibd-preven…
Enrollment in Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials: A Pooled Analysis of Screen Failure Rates Souza, et al. 📕 doi.org/10.14309/ajg.0… @MLongMD @JasmohanBajaj @mhenrique028 @SamiraMKhalil
@Inst_of_Liver @KingsCollegeLon @PROMISE_Trial @KCLImmunoMicro @BoppPtrial @REDUCe2study @NIHRresearch @BritSocGastro @LiverTrust @EASLedu @EuropeLiver @LiverTrust @AASLDtweets @ebtapper @JasmohanBajaj @OTavabie #livertwitter
🧠New EASL Policy Dialogue! Mind & Liver: Bridging the Gap Between Mental and Liver Health Mental and liver health are deeply connected, yet they are often treated separately. In this newly released episode, Dr. Victoria Kronsten, Kings College tells us about the hidden mental…
The July issue of the #RedJournal is here! Explore this month's articles, including a new ACG Clinical Guideline: Preventive Care in IBD! 📕 amjgastro.com @MLongMD @JasmohanBajaj @FarrayeIBD @dr_fcalderaibd @GilMelmedMD @EdBarnesMD @berkeleydoc @SunandaKaneMD
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus Laun, et al. 📕 bit.ly/4k21TbF @MLongMD @JasmohanBajaj @DanielLunz @AndrewKalra23 @CadmanLeggett @JobeBlair @smrnjit @oioffe
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Metopimazine Mesylate (NG101) in Participants With Gastroparesis Loesch, Hamza, De Colle, Lembo, et al. 📕 bit.ly/4kblHt4 #RapidRCTinAJG
📢 NEW in @HEP_Journal 📢@JasmohanBajaj & #VCU, @RichmondVAMC and @MayoClinic co-authors find smartphone app, designed to help people with cirrhosis manage their health at home, shows promise in reducing avoidable hospital visits. bit.ly/4lNtTB9
#MASLD➡️Not just Western and not just in adults. Scary data for our future unless we act now! @AmCollegeGastro @NASH_and_coffee @GlobalLiver @juanpabloarab
Longitudinal Associations Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Subclinical Cardiovascular Measures in Chinese Children Qiao, et al. 📕 bit.ly/4eb7MBX @MLongMD @JasmohanBajaj @JazzminZheng